These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8453782)

  • 21. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic nephritis induced by antibodies reacting with glomerular-bound immune complexes.
    van Es LA; Blok AP; Schoenfield L; Glassock RJ
    Kidney Int; 1977 Feb; 11(2):106-15. PubMed ID: 321857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the anticomplementary agent, K-76 monocarboxylic acid, on experimental immune complex glomerulonephritis in rats.
    Iida H; Izumino K; Asaka M; Takata M; Mizumura Y; Sasayama S
    Clin Exp Immunol; 1987 Jan; 67(1):130-4. PubMed ID: 3497741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophage-dependent glomerulonephritis.
    Cattell V; Smith J; Cook HT
    Clin Exp Immunol; 1990 Feb; 79(2):260-5. PubMed ID: 2311303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
    Izumino K; Iida H; Asaka M; Mizumura Y; Sasayama S
    Nephron; 1986; 43(1):56-61. PubMed ID: 2939358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
    Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
    Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the macrophage in experimental chronic immune complex glomerulonephritis.
    Becker GJ; Hancock WW; Stow JL; Glasgow EF; Atkins RC; Thomson NM
    Nephron; 1982; 32(3):227-33. PubMed ID: 6218416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Participation of antigen presenting cells in glomerulonephritis.
    Shigematsu H; Yano A
    Acta Pathol Jpn; 1986 Apr; 36(4):489-97. PubMed ID: 2425549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic serum sickness glomerulonephritis: passive immunisation inhibits the removal of glomerular antigen and electron dense deposits.
    Furness PN; Turner DR
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(6):551-3. PubMed ID: 3144089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis.
    Lan HY; Nikolic-Paterson DJ; Mu W; Atkins RC
    Kidney Int; 1995 Sep; 48(3):753-60. PubMed ID: 7474661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of cyclosporin A on experimental glomerulonephritis in rabbits].
    Kurunczi S; Dzengel M; Hosszu Z
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):211-5. PubMed ID: 2192271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect of cyclosporin A and steroid on serum sickness type nephritis in the rat. 1. Suppression of the antibody response and induction of glomerulonephritis.
    Shigematsu H; Koyama A
    Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1109-14. PubMed ID: 3216554
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigen size influences the type of glomerular pathology in chronic serum sickness.
    Hogendoorn PC; van Dorst EB; van der Burg SH; Bruijn JA; Daha MR; Hoedemaeker PJ; Fleuren GJ
    Nephrol Dial Transplant; 1993; 8(8):703-10. PubMed ID: 8414155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A prevents proteinuria in an active model of membranous nephropathy in rats.
    Thaiss F; Schoeppe W; Willaredt-Stoll JG; Batsford S; Mihatsch MJ
    Lab Invest; 1989 Dec; 61(6):661-9. PubMed ID: 2689773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-mediated proliferation of proximal tubule cells.
    Brodkin M; Noble B
    Clin Exp Immunol; 1988 Jan; 71(1):107-12. PubMed ID: 3258199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum sickness nephritis].
    Shigematsu H
    Nihon Rinsho; 1977 Jun; 35(6):2155-9. PubMed ID: 916231
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of cyclosporin A on rabbit nephrotoxic glomerulonephritis.
    Kurunczi S; Mark I
    Int J Exp Pathol; 1993 Feb; 74(1):55-63. PubMed ID: 8471535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the immunosuppressive agent, ciclosporin, on experimental immune complex glomerulonephritis in rats.
    Fujita M; Iida H; Asaka M; Izumino K; Takata M; Sasayama S
    Nephron; 1991; 57(2):201-5. PubMed ID: 1826940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory interactions of alphabeta and gammadelta T cells in glomerulonephritis.
    Rosenkranz AR; Knight S; Sethi S; Alexander SI; Cotran RS; Mayadas TN
    Kidney Int; 2000 Sep; 58(3):1055-66. PubMed ID: 10972670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage-induced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibody-initiated experimental glomerulonephritis.
    Holdsworth SR; Neale TJ
    Lab Invest; 1984 Aug; 51(2):172-80. PubMed ID: 6611452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.